Thursday, September 4, 2008

Teva Introduces Nicardipine Hydrochloride Injection

September 3, 2008 – Teva Health Systems is pleased to announce the introduction and availability of the first generic Nicardipine Hydrochloride Injection. This product is AP rated to Cardene®* I.V. Nicardipine HCl Injection is available as 2.5 mg/mL-25 mg, in single dose amber glass vials.

The details can be read here.

0 comments:

This blog is published for information purpose only. It contains no legal advice. I assume no legal responsibility for the views/information expressed here. This blog is my personal website and the views expressed in this blog are my own and do not necessarily reflect the views of any former, current or future employers or employees of mine. All information on the present blog should be double checked for its accuracy and applicability.